» Articles » PMID: 8183913

Hepatocyte Growth Factor Prevents Acute Renal Failure and Accelerates Renal Regeneration in Mice

Overview
Specialty Science
Date 1994 May 10
PMID 8183913
Citations 86
Authors
Affiliations
Soon will be listed here.
Abstract

Although acute renal failure is encountered with administration of nephrotoxic drugs, ischemia, or unilateral nephrectomy, there has been no effective drug which can be used in case of acute renal failure. Hepatocyte growth factor (HGF) is a potent hepatotropic factor for liver regeneration and is known to have mitogenic, motogenic, and morphogenic activities for various epithelial cells, including renal tubular cells. Intravenous injection of recombinant human HGF into mice remarkably suppressed increases in blood urea nitrogen and serum creatinine caused by administration of cisplatin, a widely used antitumor drug, or HgCl2, thereby indicating that HGF strongly prevented the onset of acute renal dysfunction. Moreover, exogenous HGF stimulated DNA synthesis of renal tubular cells after renal injuries caused by HgCl2 administration and unilateral nephrectomy and induced reconstruction of the normal renal tissue structure in vivo. Taken together with our previous finding that expression of HGF was rapidly induced after renal injuries, these results allow us to conclude that HGF may be the long-sought renotropic factor for renal regeneration and may prove to be effective treatment for patients with renal dysfunction, especially that caused by cisplatin.

Citing Articles

New drugs for acute kidney injury.

Hariri G, Legrand M J Intensive Med. 2025; 5(1):3-11.

PMID: 39872831 PMC: 11763585. DOI: 10.1016/j.jointm.2024.08.001.


MET Activation in Lung Cancer and Response to Targeted Therapies.

Okun S, Lu D, Sew K, Subramaniam A, Lockwood W Cancers (Basel). 2025; 17(2).

PMID: 39858062 PMC: 11764361. DOI: 10.3390/cancers17020281.


Blood flow-induced angiocrine signals promote organ growth and regeneration.

Follert P, Grosse-Segerath L, Lammert E Bioessays. 2024; 47(2):e2400207.

PMID: 39529434 PMC: 11755702. DOI: 10.1002/bies.202400207.


In vitro immuno-prevention of nitration/dysfunction of myogenic stem cell activator HGF, towards developing a strategy for age-related muscle atrophy.

Tanaka S, Elgaabari A, Seki M, Kuwakado S, Zushi K, Miyamoto J Aging Cell. 2024; 23(10):e14337.

PMID: 39297318 PMC: 11464115. DOI: 10.1111/acel.14337.


Adverse effects of graft congestion and ameliorative effects of hepatocyte growth factor after liver transplantation in rats.

Aoki H, Ito T, Hirata M, Okumura S, Masano Y, Ogawa E Liver Transpl. 2024; 31(1):11-23.

PMID: 39225679 PMC: 11643138. DOI: 10.1097/LVT.0000000000000449.


References
1.
Johnson H, Vera Roman J . Compensatory renal enlargement. Hypertrophy versus hyperplasia. Am J Pathol. 1966; 49(1):1-13. PMC: 1916466. View

2.
Ishiki Y, Ohnishi H, Muto Y, Matsumoto K, Nakamura T . Direct evidence that hepatocyte growth factor is a hepatotrophic factor for liver regeneration and has a potent antihepatitis effect in vivo. Hepatology. 1992; 16(5):1227-35. View

3.
Ryffel B, Donatsch P, Madorin M, Matter B, Ruttimann G, Schon H . Toxicological evaluation of cyclosporin A. Arch Toxicol. 1983; 53(2):107-41. DOI: 10.1007/BF00302721. View

4.
Nakamura T, Teramoto H, Ichihara A . Purification and characterization of a growth factor from rat platelets for mature parenchymal hepatocytes in primary cultures. Proc Natl Acad Sci U S A. 1986; 83(17):6489-93. PMC: 386529. DOI: 10.1073/pnas.83.17.6489. View

5.
Nakamura T, Nawa K, Ichihara A, Kaise N, Nishino T . Purification and subunit structure of hepatocyte growth factor from rat platelets. FEBS Lett. 1987; 224(2):311-6. DOI: 10.1016/0014-5793(87)80475-1. View